These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20074581)

  • 21. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Chen D; Chan R; Waxman S; Jing Y
    Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1.
    Kajiguchi T; Yamamoto K; Hossain K; Akhand AA; Nakashima I; Naoe T; Saito H; Emi N
    Leukemia; 2003 Nov; 17(11):2189-95. PubMed ID: 12931215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of ROS/ASMase/JNK signalling pathway in inhibiting UVA-induced apoptosis of HaCaT cells by polypeptide from Chlamys farreri.
    Xing YX; Li P; Miao YX; Du W; Wang CB
    Free Radic Res; 2008 Jan; 42(1):12-9. PubMed ID: 18324519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JNK1/2 inhibitor reduces dengue virus-induced liver injury.
    Sreekanth GP; Chuncharunee A; Cheunsuchon B; Noisakran S; Yenchitsomanus PT; Limjindaporn T
    Antiviral Res; 2017 May; 141():7-18. PubMed ID: 28188818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings.
    Liu ZM; Tseng HY; Yeh BW; Wu WJ; Huang HS
    Arch Toxicol; 2015 Dec; 89(12):2229-41. PubMed ID: 25537191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
    Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative regulation of ASK1 by p21Cip1 involves a small domain that includes Serine 98 that is phosphorylated by ASK1 in vivo.
    Zhan J; Easton JB; Huang S; Mishra A; Xiao L; Lacy ER; Kriwacki RW; Houghton PJ
    Mol Cell Biol; 2007 May; 27(9):3530-41. PubMed ID: 17325029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
    Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
    J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells.
    Potin S; Bertoglio J; Bréard J
    FEBS Lett; 2007 Jan; 581(1):118-24. PubMed ID: 17182041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EVI-1 modulates arsenic trioxide induced apoptosis through JNK signalling pathway in leukemia cells.
    Lang W; Zhu J; Chen F; Cai J; Zhong J
    Exp Cell Res; 2019 Jan; 374(1):140-151. PubMed ID: 30472098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade.
    Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR
    Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.
    Yan H; Wang YC; Li D; Wang Y; Liu W; Wu YL; Chen GQ
    Leukemia; 2007 Jul; 21(7):1488-95. PubMed ID: 17495969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
    Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells.
    Yang SH; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
    Leuk Res; 2007 Oct; 31(10):1413-20. PubMed ID: 17397922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.